Global Biotechnology Market Size & Trends Report Segmented by Technology (Nanobiotechnology, DNA Sequencing, Cell-based Assays, Fermentation Technology, PCR, Chromatography), Offering (Biopharmaceuticals, Bio-services, Bio-agriculture) By Application (Health, Medical, Industrial, Environmental) & Regional Forecasts to 2029
The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. To learn more about the research report, download a sample report.
Report Overview
Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop resilience, and creating environmentally friendly industrial processes. Innovations like gene editing, synthetic biology, and regenerative medicine continue to expand biotechnology’s applications, addressing global challenges in medicine, food security, and sustainable resource management.
To learn more about this report, download the PDF brochure
Advancements in genetic engineering and genomics to propel market demand
Advancements in genetic engineering and genomics are significantly propelling the biotechnology market by enabling precise modifications at the genetic level, fostering breakthroughs in personalized medicine, gene therapies, and biopharmaceuticals. Techniques like CRISPR-Cas9 and next-generation sequencing (NGS) have transformed disease treatment and prevention, allowing for targeted therapies that cater to individual genetic profiles. These innovations support the development of therapies for previously untreatable diseases and improve crop resilience in agriculture. Additionally, genomics-based data analytics facilitate faster drug discovery and development processes, reducing R&D costs and time-to-market. This precision and efficiency are attracting substantial investments across the biotechnology sector.
Growing demand for biopharmaceuticals is driving the market growth
The growing demand for biopharmaceuticals is a major driver of biotechnology market growth, as biologic drugs like monoclonal antibodies, vaccines, and cell therapies offer targeted treatments with fewer side effects compared to traditional medications. Biopharmaceuticals are particularly effective in treating complex chronic diseases, including cancer, autoimmune disorders, and genetic conditions. Their efficacy and specificity are fueling global demand, prompting biopharma companies to expand R&D investments. Additionally, advancements in biotechnology, such as recombinant DNA technology and advanced bio-manufacturing processes, enable efficient biopharmaceutical production, supporting rapid market expansion and the development of more personalized, high-impact therapies.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global biotechnology market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Novartis AG, Biogen, Abbott, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, and Merck KGaA; among others. Some of the key strategies adopted by market players include new product and service development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2023 |
| Historical Data | 2022 - 2023 |
| Forecast Period | 2024 - 2029 |
| Growth Rate | CAGR of 13-15% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Technology, Application, Offering |
| Regional Scope |
|
| Key Companies Mapped | F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Novartis AG, Biogen, Abbott, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, and Merck KGaA among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global biotechnology market at the regional- and country-level from 2022 to 2029. The report further segments the market based on technology, application, and offering.
- Market Size & Forecast (2022-2029), By Technology, USD Million
- Nanobiotechnology
- Tissue Engineering and Regenerative Medicine
- DNA Sequencing and Genomics
- Cell-based Assays
- Fermentation Technology
- PCR Technology
- Chromatography
- CRISPR and Gene Editing
- Synthetic Biology
- Cell and Gene Therapy
- Bioinformatics
- Others
- Market Size & Forecast (2022-2029), By Application, USD Million
- Healthcare and Medical Biotechnology
- Agricultural Biotechnology
- Industrial Biotechnology
- Environmental Biotechnology
- Others
- Market Size & Forecast (2022-2029), By Offering, USD Million
- Biopharmaceuticals
- Bio-services
- Bio-agriculture Products
- Bio-industrial Products
- Diagnostic and Research Reagent
- Others
- Market Size & Forecast (2022-2029), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
-
What is the market size & forecast of the biotechnology market?
-
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the biotechnology market?
-
What are the key trends defining the market?
-
What are the major factors impacting the market?
-
What are the opportunities prevailing in the market?
-
Which region has the highest share in the global market?
-
Which region is expected to witness the highest growth rate in the next 5 years?
-
Who are the major players operating in the market?
-
What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2023-2024)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Biotechnology Market Snapshot (2023-2029)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Advancements in genetic engineering and genomics
- Growing demand for biopharmaceuticals
- Rising incidence of chronic diseases
- Growth in environmental and agricultural biotechnology
- Increased investment in R&D
- Growing demand for synthetic biology
- Presence of favourable government initiatives
- Restraints
- High costs of biotechnology R&D and product development
- Stringent regulatory frameworks
- Ethical and social concerns
- Risks associated with genetically modified organisms and crops
- Limited access to skilled workforce
- Opportunities
- Growth of personalized medicine
- Emerging markets
- Rising use of biotechnology in agriculture and food sectors
- Adoption of artificial intelligence and data analytics
- Key Market Trends
- CRISPR and gene editing
- Cell and gene therapies
- Biomanufacturing innovations
- Unmet Market Needs
- Industry Speaks
- Regulatory Analysis
- Global Biotechnology Market Size & Forecast (2022-2029), By Technology, USD Million
- Introduction
- Nanobiotechnology
- Tissue Engineering and Regenerative Medicine
- DNA Sequencing and Genomics
- Cell-based Assays
- Fermentation Technology
- PCR Technology
- Chromatography
- CRISPR and Gene Editing
- Synthetic Biology
- Cell and Gene Therapy
- Bioinformatics
- Others
- Global Biotechnology Market Size & Forecast (2022-2029), By Application, USD Million
- Introduction
- Healthcare and Medical Biotechnology
- Agricultural Biotechnology
- Industrial Biotechnology
- Environmental Biotechnology
- Others
- Global Biotechnology Market Size & Forecast (2022-2029), By Offering, USD Million
- Introduction
- Biopharmaceuticals
- Bio-services
- Bio-agriculture Products
- Bio-industrial Products
- Diagnostic and Research Reagent
- Others
- Global Biotechnology Market Size & Forecast (2022-2029), By Region, USD Million
- Introduction
- North America Biotechnology Market Size & Forecast (2022-2029), By Country, USD Million
- US
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Canada
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- US
- Europe Biotechnology Market Size & Forecast (2022-2029), By Country, USD Million
- UK
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Germany
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- France
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Italy
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Spain
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Rest of Europe
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- UK
- North America Biotechnology Market Size & Forecast (2022-2029), By Country, USD Million
- Introduction
-
-
- Asia Pacific (APAC) Biotechnology Market Size & Forecast (2022-2029), By Country, USD Million
- China
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Japan
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- India
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- China
- Latin America (LATAM) Biotechnology Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Middle East & Africa (MEA) Biotechnology Market Size & Forecast (2022-2029), USD Million
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Offering (USD Million)
- Asia Pacific (APAC) Biotechnology Market Size & Forecast (2022-2029), By Country, USD Million
-
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2023)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product and Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Hoffmann-La Roche Ltd
- Gilead Sciences, Inc.
- Bristol-Myers Squibb Company
- Novartis AG
- Biogen
- Abbott
- Pfizer Inc.
- Amgen Inc.
- Novo Nordisk A/S
- Merck KGaA
- Other Prominent Players
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals and Specialty Clinics; Academic and Research Institutions, Industrial and Manufacturing Companies; and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
